49 research outputs found
Figure 4. a in Genus Chersotis Boisduval, 1840 (Lepidoptera: Noctuidae) in Croatia with some notes on the other Balkan countries: DNA barcoding, distribution and new records
Figure 4. a) Ch. fimbriola thurneri, female. Albania, Korca County, above Boboshticë Village, 1225m, N40°32'26"; E020°47'31", 08.VII.2016, S. Beshkov & A. Nahirnić leg., b) Ch. fimbriola thurneri, male genitalia with everted vesica. Gen. prep. 4./22.XII.2020, S. Beshkov. AL, Korca County, above Boboshticë, 1225m, N40°32'26"; E020°47'31", 08.VII.2016, S. Beshkov & A. Nahirnić leg. c.) Ch. fimbriola ssp., male genitalia with everted vesica. Gen. prep. 6./22.XII.2020, S. Beshkov. North Macedonia, above Demir Kapija Town, 244m, N41°22'58"; E022°11'45", 10.VI.2018, S. Beshkov & A. Nahirnić leg. d) Ch. fimbriola thurneri, male genitalia with everted vesica. Gen. prep. 5./22.XII.2020, S. Beshkov. AL, Korca County, above Drenovë Village, 1050m, N40°35'18"; E020°48'23", 7.VII.2016, S. Beshkov & A. Nahirnić leg. e) Ch. fimbriola ssp.female genitalia. Gen. prep. 1./22.XI.1999, S. Beshkov. SW Bulgaria, Pirin Mts, Yane Sandansky Chaler, 1200 m alt., 29.VII.1969, det. and in coll. of Al. Slivov in IBER (Sofia).Published as part of Koren, Toni, Podnar, Martina, Vojvoda, Ana Mrnjavčić, Beshkov, Stoyan, Mihoci, Iva & Kučinić, Mladen, 2021, Genus Chersotis Boisduval, 1840 (Lepidoptera: Noctuidae) in Croatia with some notes on the other Balkan countries: DNA barcoding, distribution and new records, pp. 86-108 in Ecologica Montenegrina 48 on page 99, DOI: 10.37828/em.2021.48.12, http://zenodo.org/record/802930
Beshkov or the Long Road to the Principle of Social Rehabilitation of Offenders
This Insight provides an analysis of the first preliminary ruling (Court of Justice, judgment of 21 September 2017, case C-171/16, Beshkov) concerning some provisions of the Council Framework Decision 2008/675/JHA of 24 July 2008 on taking account of convictions in the Member States of the European Union in the course of new criminal proceedings. The Court of Justice was asked: a) to interpret the concept of “criminal proceedings” within the meaning of the Framework Decision; b) to explain whether or not this expression had to be connected to a finding of guilt; c) to make clear whether the procedure for taking into account a previous conviction could be initiated only by the Member State or also by the convicted person; and d) to point out the consequences that taking into account previous convictions could have on the manner of execution of a foreign judgment. In this context, AG Bot recalled the notion of social rehabilitation of offenders as a principle inspiring the Framework Decision that should have been considered in order to answer at least one of the questions referred to the Court. As the Court did not take it into consideration, the purpose of this Insight is to identify a possible interpretative path the Court might follow to acknowledge the social rehabilitation of offenders as a general principle of EU law
Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria
Little information is available about the prevalence of resistance mutations to reverse transcriptase (RT) and protease (PR) inhibitors of HIV-1, after the introduction of antiretroviral treatment in Bulgaria. To fill this gap, we analyzed 80 plasma samples from HIV-1-infected Bulgarian patients, 22 naive at antiretroviral treatment (ARV) and 58 ARV experienced. The subtypes B and A resulted in the two most prevalent (41 patients and 18 patients, respectively). The proportion of subtype B among naive and treated patients was similar in each group (57% vs. 47%, p = 0.62), while a major proportion of subtypes A was present in drug-naive patients rather than in treated patients [8/22 (36.4%) vs. 10/58 (17.2%), p = 0.08]. Two (9.1%) naive patients and 40 (70.1%) drug-experienced patients had viruses carrying at least one mutation conferring resistance to ARV drugs. Of 57 patients having experience with nucleoside reverse transcriptase inhibitors (NRTI), 32 (56.1%) had NRTI resistance mutations; 8/14 (57.2%) patients having experience with non-NRTI (NNRTI) had viruses carrying NNRTI resistance mutations; and 21/46 (45.7%) patients having experience with protease inhibitors (PI) had PI resistance mutations. The commonest resistance mutations resulted in the NRTI mutation M184V (42.1%) and the PI mutation L90M (24.1%). In conclusion, due to the detection of the substantial transmission of resistant variants to newly infected individuals, continuous surveillance is required, since greater access to highly active antiretroviral therapy (HAART) will be expected in Bulgaria. Furthermore, surveillance of PR and RT sequences is also convenient to monitor the introduction of nonsubtype B HIV-1 strains in Bulgaria
The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries
FIRST REPORT OF DESERTOBIA ANKERARIA (STAUDINGER, 1861) (LEPIDOPTERA: GEOMETRIDAE) IN SERBIA
Desertobia ankeraria (Staudinger, 1861) is a Natura 2000 target species and it is included in Anex II of EEC 92/43 Habitat Directive. It is strictly protected species in Slovenia, Croatia and Hungary. It is recorded for the first time in Serbia in Pčinja river valley near Trgovište at locality Vražji Kamen. The species was attracted to the light trap on March 15th, 2016. D. ankeraria usually inhabits inhabits xerothermic oak woodlands and caterpillars are feeding on leaves of Downy Oak Quercus pubescens Wild. and Sessile Oak Q. petraea (Matt.) Liebl. Such habitat and Downy Oak were found at Vražji Kamen during our previous research in southern Serbia
Deposition and Properties of Thin PECVD Carbon Films After Rapid Thermal Annealing
In this work the properties of PECVD-carbon films before and after Rapid Thermal Annealing (RTA) are presented. The thickness of the investigated films is in the range 50 - 6000Å. The layers are annealed at 1400°C for different times of 1 s to 3 min in vacuum 5 x 10-5 Torr. Raman investigation has been performed before and after annealing
Patterns of transmitted HIV drug resistance in Europe vary by risk group
Background: In Europe, a continuous programme (SPREAD) has been in place for ten years to study transmission of drug resistant HIV. We analysed time trends of transmitted drug resistance mutations (TDRM) in relation to the risk behaviour reported. Methods: HIV-1 patients newly diagnosed in 27 countries from 2002 through 2007 were included. Inclusion was representative for risk group and geographical distribution in the participating countries in Europe. Trends over time were calculated by logistic regression. Results: From the 4317 patients included, the majority was men-having-sex-with-men -MSM (2084, 48%), followed by heterosexuals (1501, 35%) and injection drug users (IDU) (355, 8%). MSM were more often from Western Europe origin, infected with subtype B virus, and recently infected (<1 year) (p<0.001). The prevalence of TDRM was highest in MSM (prevalence of 11.1%), followed by heterosexuals (6.6%) and IDU (5.1%, p,0.001). TDRM was predominantly ascribed to nucleoside reverse transcriptase inhibitors (NRTI) with a prevalence of 6.6% in MSM, 3.3% in heterosexuals and 2.0% in IDU (p = 0.001). A significant increase in resistance to non- nucleoside reverse transcriptase inhibitors (NNRTIs) and a decrease in resistance to protease inhibitors was observed in MSM (p = 0.008 and p = 0.006, respectively), but not in heterosexual patients (p = 0.68 and p = 0.14, respectively). Conclusions: MSM showed to have significantly higher TDRM prevalence compared to heterosexuals and IDU. The increasing NNRTI resistance in MSM is likely to negatively influence the therapy response of first-line therapy, as most include NNRTI drugs
